Stanford University
Showing 22,341-22,360 of 36,940 Results
-
Amar Mukunda
Masters Student in Engineering, admitted Winter 2024
BioAmar Mukunda pursued his Master's degree in Energy and Infrastructure Engineering. Amar's overall focus is developing strategies to meet America's 21st century energy and infrastructure needs while alleviating poverty the country's most economically challenged communities. Amar's degree is focused on both the technical engineering aspects of a broad range of zero carbon technologies as well as the finance and legal aspects of building large energy projects.
Amar previously served Assistant Director of Roca, one of Maryland's premier gun violence prevention programs, where he ran the organization's workforce development and and education teams. Through his role at Roca Amar was a Bloomberg fellow at Johns Hopkins University working on understanding gun violence and addiction from a public health perspective. From 2015-2016 Amar was a Fulbright Scholar researching artificial intelligence and machine learning in the field of natural language processing. He graduated from Amherst College Magna Cum Laude in 2015 with majors in Computer Science and Geology. -
Pavithra Mukunda
Clinical Rsch Mgr, Psych/Public Mental Health & Population Sciences
Current Role at StanfordClinical Research Manager
-
Elvis Raymond Mukwikwi, MD
Fellow in Psychiatry and Behavioral Sciences
BioDr. Elvis Raymond Mukwikwi is a geriatric psychiatry fellow at Stanford University. He completed his medical training at the University of Montreal, followed by a specialization in psychiatry at McGill University. In addition to his clinical training, Dr. Mukwikwi is actively involved in neuropsychiatry research and has published work focusing on frontotemporal dementia. Beyond his clinical work, he is dedicated to patient advocacy.
-
Nand Mulchandani
Visiting Fellow, HOOVER RESEARCH
BioNand Mulchandani is a serial entrepreneur, having co-founded multiple companies with successful exits in the enterprise infrastructure and security space.
Most recently, Nand was the Vice President of Market Development and Strategy for Citrix. In this role, Nand has led numerous projects in opening up new markets for the company, helping to develop and launch new products, strategy, and building partnerships and business alliances to execute on these initiatives.
Nand joined Citrix through its acquisition of ScaleXtreme in May 2014, where Nand was the CEO and Co-Founder. ScaleXtreme built one of the first SaaS datacenter and cloud automation systems. Accel and Ignition Partners were the investors in ScaleXtreme.
Prior to co-founding ScaleXtreme, Nand was an Entrepreneur-In-Residence at Accel Partners, where he started work on the company that became ScaleXtreme, in addition to working on projects in cloud computing, consumer internet, as well as advising a number of companies on product and growth strategies.
Nand was CEO of OpenDNS, where he lead the company through a growth phase in DNS traffic, consumer router integrations, and a complete repositioning of the company to the enterprise security space. Nand also led the first venture round that the company raised from Sequoia Capital and Greylock Partners. OpenDNS was later acquired by Cisco in 2014.
Previously, Nand was Senior Director of Product Management and Marketing at VMware, responsible for security strategy, product management, and security marketing. Before VMWare, Nand was Vice President of Marketing and Business Development at Determina Inc., which was acquired by VMware in August 2007. Nand was the founding CEO of Determina where he led the company from inception to early revenue stage. Determina was backed by Bessemer Venture Partners, the Mayfield Fund, and US Venture Partners.
Prior to Determina, Nand was co-founder and VP Product Management at Oblix, where he helped create the Identity & Access Management market and position Oblix as a leader in this space. Oblix was backed by Kleiner, Perkins, Caufield & Byers and other leading venture firms, and was acquired by Oracle in 2005.
Nand started his career at Sun Microsystems, working on compilers and optimization, including work on the first Java compilers and the UltraSPARC chips. -
Liam Edward Mulhall
Software Developer, Biomedical Data Science
Current Role at StanfordLiam develops and maintains the HLA Curation Interface, a tool that supports the assessment of HLA alleles and haplotypes for use in precision medicine and research. He also works on internal tools used by the Stanford ClinGen team.
-
Sandeepa Mullady, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Mullady is a board-certified neurologist providing care at Stanford Health Care’s Memory Disorders Center. She completed a memory and aging fellowship at the University of California, San Francisco. She is also a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine.
Dr. Mullady specializes in memory disorders and aging. She has a particular interest in caring for homeless patients with neurological conditions.
She is passionate about educating both patients and colleagues. She seeks to improve health literacy in underserved communities. She has mentored students, organized seminars and conferences, and lectured about rare neurological cases and issues related to social justice.
Dr. Mullady excels in community outreach, health advocacy, and leadership. She has organized and directed outreach programs at women’s shelters, clinics for the homeless, and an alcohol and drug rehabilitation center. She has also developed programs to encourage childhood reading at home and to educate underserved communities about neurodegenerative disorders.
She has published peer-reviewed articles in Frontiers of Neurology that report her research on the effects of homelessness on neurocognitive health. She has also presented posters at regional and national conferences on the topics of interprofessional health coaching and the effects of homelessness on mental function. -
Ann Mullally
George E. Becker Professor in Medicine
Current Research and Scholarly InterestsDr. Ann Mullally's aboratory studies the genetics, biology and therapy of myeloid blood cancers, with a focus on myeloproliferative neoplasms (MPN). Using primary human samples, mouse models, genomics, single-cell sequencing and CRISPR, as well as cellular and molecular biology, the lab has investigated the key genetic events underlying MPN pathogenesis. Dr. Mullally’s lab elucidated the mechanism by which mutant calreticulin (CALR) is oncogenic and causes MPN.
